Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 628 of 1,261
  1. US 9676823

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Rhode Island Council on Postsecondary Education (statutory successor to Board of Governors for Higher Education, State of Rhode Island and Providence Plantations) · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  2. US 9675615

    2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  3. US 9676802

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  4. US 9675598

    Compositions of tolperisone

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  5. US 9676788

    Aza-epoxy-guaiane derivatives and treatment of cancer

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  6. US 9675550

    Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  7. US 9669076

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  8. US 9669004

    Daidzein analogs as treatment for cancer

    United States Department of Agriculture · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  9. US 9669091

    Vaccines having an antigen and interleukin-23 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  10. US 9670157

    Benzylamine derivatives

    KalVista Pharmaceuticals Limited · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  11. US 9669064

    Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or promoting expression of collagen using Ixora parviflora leaf extract

    China Medical University · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  12. US 9670506

    Modified immunization vectors

    THE ARIZONA BOARD OF REGENTS · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  13. US 9670251

    ANG-(1-7) derivative oligopeptides and methods for using and producing the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  14. US 9670213

    Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor

    East China University of Science and Technology · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  15. US 9669069

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  16. US 9670177

    Crystalline C21H22Cl2N4O2 malonate

    Biomed Valley Discoveries, Inc. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  17. US 9670143

    (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  18. US 9669098

    Metal-organic frameworks with exceptionally large pore aperatures

    The Regents of the University of California · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  19. US 9670152

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  20. US 9670141

    (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma

    Northwestern University · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  21. US 9669027

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  22. US 9670215

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  23. US 9669016

    Antiparasitic effect of Bis[3,5-Bis(Benzylidene)-4-Oxo-1-Piperidinyl]amide Derivatives

    The Board of Regents of the University of Texas System · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  24. US 9670186

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.